
Before your surgery

It is important to discuss your surgical options, along with details about surgery preparation and recovery, with your surgeon, doctor, and medical team. Some of your surgical options will depend on how much the cancer has spread in your body. Whether you have minimally invasive surgery or open surgery will usually not change the size of the colon or rectum area that the surgeon needs to remove.
Preparation for surgery is similar to the preparation before colonoscopy because the colon must be clean and empty.
Medications
Patients should talk to their medical team about regular medications and any changes in preparation for surgery. For example, blood thinning medications should be stopped before surgery because they can increase bleeding during the procedure. Aspirin and aspirin-containing products should be avoided two weeks before surgery. All non-steroidal anti-inflammatory medications (such as Advil, Motrin, Nuprin, etc.) should be avoided.
Anxiety
It is normal to feel anxious before surgery. Every person experiences anxiety differently. Some of the more common symptoms include a pounding heart, irregular heartbeat, shortness of breath, nausea, and sleep problems. People also cope with their anxiety in different ways. Most hospitals have dedicated staff members such as counselors, social workers, and volunteers that may offer support. The Alliance also offers patient and family support navigators, who can be reached here.
Smoking
Smoking may complicate and slow down your recovery. It is best to stop smoking or use nicotine alternatives as soon as you arrange for your surgery.
Top resources

Lexie Haglund: Beating stage IV CRC
Discover how knowing her G12C biomarker guided Lexie’s stage IV colorectal cancer treatment — from a shock diagnosis to HIPEC surgery — and why screening, research, and self-advocacy matter.

HAI liver pump for mCRC offers second chances
Discover how Hope overcame stage IV colorectal cancer with an innovative HAI liver pump, staying active and proving that second chances are possible.

Treatment for KRAS G12C-mutated metastatic CRC approved by FDA
The U.S. Food and Drug Administration has approved sotorasib in combination with panitumumab for the treatment of adult patients with KRAS G12C-mutated metastatic colorectal cancer.